| Literature DB >> 28693176 |
Noriko Nishiyama1, Kenji Kanenishi2, Hirohito Mori1, Hideki Kobara1, Shintaro Fujihara1, Taiga Chiyo1, Nobuya Kobayashi1, Tae Matsunaga1, Maki Ayaki1, Tatsuo Yachida1, Ayako Fujimori1, Makoto Oryu1, Chiaki Tenkumo2, Megumi Ishibashi2, Uiko Hanaoka2, Toshiyuki Hata2, Yumi Miyai3, Kyuichi Kadota3, Reiji Haba3, Tsutomu Masaki1.
Abstract
Narrow band imaging with magnifying endoscopy (NBI-ME), which is useful for the assessment of micro-vessels, has excellent diagnostic potential for early gastrointestinal epithelial neoplasia. Conventional diagnostic tools for uterine cervical epithelial tumors are still unsatisfactory. An accurate diagnostic tool for uterine cervical epithelial tumors is required to preserve the reproductive ability of young women with uterine cervical tumors. Flexible NBI-ME was performed in patients with cervical squamous cell lesions that required further examinations based on their Pap smear results (cytology ≥ low-grade squamous intraepithelial lesion) at Kagawa University Hospital between April 2014 and April 2015. NBI-ME results concordant with the punch biopsy sites were compared with the histological results. A retrospective review of the NBI-ME images identified abnormal NBI-ME results regarding micro-vascular patterns. All images were categorized as having abnormal features. NBI-ME revealed the following vascular pattern differences of different stage tumors: Dot-like vessels without irregular arrangements and high density in cervical intraepithelial neoplasia (CIN) CIN1-CIN2; dot-like vessels with irregular arrangements and high density in CIN3-carcinoma in situ; crawling vessels in minimum invasive cancer; and willow branch vessels and new tumor vessels in invasive cancer. NBI-ME may be an effective diagnostic tool for uterine cervical epithelial tumors, which may lead to the establishment of a novel classification system.Entities:
Keywords: cooperative study; flexible magnifying endoscopy; microvascular classification; narrow band imaging; uterine cervical tumors
Year: 2017 PMID: 28693176 PMCID: PMC5494908 DOI: 10.3892/ol.2017.6157
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967